Tasimelteon
2022P001873
Phase 1 small_molecule terminated
Quick answer
Tasimelteon for REM Behavior Disorder is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- REM Behavior Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated